Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06948838 · ClinicalTrials.gov registry record · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
A NA study of Hypertension and Hypertension Complicated, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 16,895
- Enrollment target
- 7
- Study locations
NCT06948838 is a NA study of Hypertension and Hypertension Complicated that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 16,895 participants, above the 3,471-participant average among 470 other Hypertension trials with a reported enrollment target (387% higher). The trial reports 7 study locations across 1 state.
The verdict
NCT06948838, a NA study of Hypertension and Hypertension Complicated, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 16,895 participants
- Enrollment target
- 7
- Study locations
Study Summary
High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP. Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.
Conditions Studied
Interventions
- BEHAVIORAL RBPM
- OTHER MII
Study Locations (7)
Massachusetts
- Boston Healthcare for the Homeless (BHCHP) - Boston
- Boston Medical Center Family Medicine - Boston
- Boston Medical Center, General Internal Medicine primary care - Boston
- Neighborhood Health - Boston
- Mattapan Community Health Center - Boston
- Manet Community Health Center - Quincy
- Greater Roslindale Medical and Dental Center (GRMDC) - Roslindale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,895 participants |
| Start Date | 2025-09-08 |
| Est. Completion | 2029-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06948838
The ClinicalTrials.gov registry entry for NCT06948838 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16,895 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,471-participant average among 470 other Hypertension trials with a reported enrollment target (387% higher). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which RBPM is the first listed.
NCT06948838 reports 7 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06948838 about?
NCT06948838 is a clinical study titled "Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment". High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication cla...
What is the current status of trial NCT06948838?
This trial is currently recruiting. It is a NA study. The enrollment target is 16,895 participants. The study started on 2025-09-08. Estimated completion is 2029-09.
What conditions does trial NCT06948838 study?
This clinical trial studies the following conditions: Hypertension, Hypertension Complicated.
What interventions are being tested in trial NCT06948838?
The interventions under investigation include: RBPM (BEHAVIORAL), MII (OTHER).
Who is sponsoring clinical trial NCT06948838?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06948838 being conducted?
This trial has 7 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.